Publications by authors named "Xueke She"

Claim this Profile
S
Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract.
Juan Meng, Hao Xiao, Feng Xu, Xueke She, Chuntao Liu

Immunol Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene variation profile and it's potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in China.
Jian Xu, Yao Zhou, Ke Dong, Jun Gong, Wei Xiong, Xu-Dong Shen, Xue-Ke She

Asian J Surg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of alterations in 22,432 Chinese solid tumor patients.
Guanghui Xu, Jiyang Zheng, Shu Wang, Yuhao Wang, Guixiang Li, Xueke She

Ann Transl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma.
Wenwu He, Xuefeng Leng, Tianqin Mao, Xi Luo, Lingxiao Zhou, Xudong Shen, Xueke She

Oncologist· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review.
Xiangu Ning, Yang Yu, Songjun Shao, Rong Deng, Jie Yu, Xueke She, Xudong Shen

Ann Transl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC.
Xiaolong Zhao, Fuqiang Dai, Longyong Mei, Depei Huang, Xudong Shen, Xueke She

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia.
Guanghui Xu, Yuhao Wang, Hushan Zhang, Xueke She, Jianjun Yang

Future Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.
Jun Yang, Zhengqi Wen, Wenliang Li, Xianghua Sun, Junrui Ma, Xueke She, Xudong Shen

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high MR affinity.
Corinna G Gruber, Andrea Pegoli, Christoph Müller, Lukas Grätz, Xueke She

RSC Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers.
Jin Liang, Dedian Chen, Liyao Chen, Xueke She, Hushan Zhang

Future Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M Receptor.
Xueke She, Andrea Pegoli, Corinna G Gruber, David Wifling, Jessica Carpenter

J Med Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines MR Selectivity.
Andrea Pegoli, David Wifling, Corinna G Gruber, Xueke She, Harald Hübner

J Med Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased MR Affinity and Selectivity.
Xueke She, Andrea Pegoli, Judith Mayr, Harald Hübner, Günther Bernhardt

ACS Omega· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M Muscarinic Acetylcholine Receptor.
Andrea Pegoli, Xueke She, David Wifling, Harald Hübner, Günther Bernhardt

J Med Chem· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
Max Keller, Christian Tränkle, Xueke She, Andrea Pegoli, Günther Bernhardt

Bioorg Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on the relative reactivity of three hydroxyl groups in aconitine.
Xue-Ke She, Xi-Xian Jian, Dong-Lin Chen, Qiao-Hong Chen, Feng-Peng Wang

J Asian Nat Prod Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-cardiac activity relationship of C19-diterpenoid alkaloids.
Xi-Xian Jian, Pei Tang, Xiu-Xiu Liu, Ruo-Bing Chao, Qiao-Hong Chen, Xue-Ke She

Nat Prod Commun· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversional synthesis and cytotoxic evaluation of novel taxoid analogs.
Lei Song, Qiao-Hong Chen, Xue-Ke She, Xiao-Guang Chen, Feng-Peng Wang

J Asian Nat Prod Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis